Sobhan at a glance
SOBHAN has begun producing vaccines, including Hepatitis, Meningitis,pentavalent and Influenza vaccines, based on international standards and with a vision to local and international markets. The complete procedure from production until packaging is designed and operated with the collaboration of pioneering Europeans in this field and under the supervision of leading international technology owners
SOBHAN has used its expertise to transfer the complete production technology of the Hepatitis vaccine to a local company. Moreover, with recent agreements made with Russian companies, this technology is on its way to Russia. SOBHAN is now ready to transfer the production technology of recombinant vaccines to any local and international companies with required certificates.
SOBHAN is collaborating with domestic and international universities and research institutes, using the excellent expertise of its team in the following fields: Microbiology, Genetics, Protein Engineering, fermentation and formulation. SOBHAN employs professional researchers and possesses advanced equipment which have obtained great achievements in production promotion and process engineering.
Sobhan Technologies
Each year, the Influenza vaccine is imported at great expense. After negotiations with Russia, this vaccine technology, despite its complicated production technology, is being transferred to Sobhan under the supervision of European representatives.
Tetravalent Meningitis vaccine ACWY is now passing the last phases of pilot production at the SOBHAN production site, using premier facilities with QA and QC systems complying to FDA and EMA standards. With the production of this vaccine, SOBHAN will be able to supply the local demand.
Pentavalent vaccine is a combination of Diphtheria, Pertussis, Tetanus, Hepatitis B and Hib vaccines, which provide immunity towards all of these conditions with one injection. SOBHAN is the pioneer in the local production of this vaccine, with a vision to expand to international markets.
